Elekta AB (publ) (OTCMKTS:EKTAY) Upgraded at Sanford C. Bernstein

Sanford C. Bernstein upgraded shares of Elekta AB (publ) (OTCMKTS:EKTAY) from a strong sell rating to a hold rating in a report published on Wednesday morning,Zacks.com reports.

Elekta AB (publ) Stock Down 1.9 %

Elekta AB (publ) stock opened at $5.87 on Wednesday. Elekta AB has a fifty-two week low of $5.25 and a fifty-two week high of $8.24. The company has a debt-to-equity ratio of 0.60, a quick ratio of 0.81 and a current ratio of 1.05. The firm has a 50 day moving average price of $5.63 and a 200 day moving average price of $6.11. The company has a market capitalization of $2.25 billion, a PE ratio of 23.48 and a beta of 1.22.

Elekta AB (publ) (OTCMKTS:EKTAY) last posted its earnings results on Wednesday, November 27th. The company reported $0.06 earnings per share for the quarter. Elekta AB (publ) had a net margin of 5.65% and a return on equity of 11.07%. Research analysts expect that Elekta AB will post 0.36 earnings per share for the current year.

Elekta AB (publ) Company Profile

Elekta AB (publ), a medical technology company, provides clinical solutions for treating cancer and brain disorders worldwide. The company offers Versa HD, a brain metastases solution; Elekta Unity for real-time MR visualization; Elekta Harmony, a linear accelerator; Elekta Infinity for treating a range of patients with simple-to-complex radiotherapy needs; Elekta Synergy, a digital accelerator for image guided radiation therapy; treatment and workflow management solutions; radiation and medical oncology; and other patient services.